Interaction of inhaled particles with the immune system

Particle-Lung Interactions

Volumn , Issue , 2000, Pages 626-652

  Gilmour, M Ian ^a   Koren, Hillel S ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646476483     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (93)

1. Pope CA, Dockery DW, Schwartz J. Review of epidemiological evidence of health effects of particulate air pollution. Inhal Toxicol 1995; 7:1-18.
2. Ostro BD. The association of air pollution and mortality: examining the case for inference. Arch Environ Health 1993; 48:336-342.
3. Dockery DW, Pope AC. Acute respiratory effects of particulate air pollution. Annu Rev Public Health 1994; 15:107-132.
4. Gardner DE. Effects of airborne gases and airborne particles on lung infections. In: McGrath JJ, Barnes CD, eds. Air Pollution: Physiological Effects. New York: Academic Press, 1982:48-79.
5. Selgrade MJK, Gilmour MI. Effects of gaseous air pollutants on immune responses and susceptibility to infections and allergic disease. In: Dean JH, Luster MI, Munson AE, Kimber I, eds. Immunotoxicology and Immunopharmacology. New York: Raven Press, 1994:395-411.
6. Gilmour MI. Interaction of air pollutants and pulmonary allergic responses in experimental animals. Toxicology 1995; 105:335-342.
7. Jakab GJ, Spannhake EW, Kleeberger SR, Canning BJ, Gilmour MI. The effects of ozone on immune function. Environ Health Perspect 1995; 103:77-89.
8. Green GM, Jakab GJ, Low RB, Davis GS. Defense mechanisms of the respiratory membrane. Am Rev Respir Dis 1977; 115:479-514.
9. Reynolds HB. Integrated host defense against infections. In: Crystal RG, West JB, eds. The Lung: Scientific Foundations. New York: Raven Press, 1991:1899-1911.
10. Schlesinger RB. The interaction of inhaled toxicants with respiratory tract clearance mechanisms. Crit Rev Toxicol 1990; 20:257-285.
11. Schlesinger RB. Interaction of gaseous and particulate pollutants in the respiratory tract: mechanisms and modulators. Toxicology 1995; 105:315-325.
12. Koren HS, Becker S. Antimicrobial defense mechanisms. In: Crystal RG, West JB, eds. The Lung: Scientific Foundations. New York: Raven Press, 1991:747-769.
13. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990; 141:471-501.
14. Henson PM, Johnston RB. Tissue injury in inflammation: oxidants, proteinases and cationic proteins. J Clin Invest 1987; 79:669-674.
15. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-376.
16. Brown EJ. Complement receptors, adhesion and phagocytosis. Infect Agents Dis 1992; 1:63-70.
17. Lehr RI, Lichtenstein AK, Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993; 11:105-128.
18. Liebow AA. Pulmonary angiitis and granulomatosis. Am Rev Respir Dis 1973; 108: 1-18.
19. Herberman R, Djeu J, Kay D, et al. Natural killer cells: characteristics and regulation of activity. Immunol Rev 1989; 44:43-70.
20. Haley PJ. Immunological responses within the lung after inhalation of airborne chemicals. In: Gardner D, Crapo JD, McClellan RO, eds. Toxicology of the Lung. 2nd ed. New York: Raven Press, 1993:389-416.
21. Murray MJ, Driscoll KE. Immunology of the respiratory tract. In: Parent RE, ed. Comparative Biology of the Normal Lung. Boca Raton, FL: CRC Press, 1991:725-746.
22. Edelman AS, Zolla-Pazner S. AIDS: a syndrome of immune dysregulation, dysfunction, and deficiency. FASEB J 1989; 3:22-30.
23. Plebani A, Ugazio AG, Monafo V. Selective IgA deficiency; an update. Curr Prob Dermatol 1989; 18:66-78.
24. Daniele RP. Immunology and Immunologic Diseases of the Lung. Boston: Blackwell Scientific, 1988.
25. Selgrade MJK, Cooper K, Devlin RB, Van Loveren H, Biagini RE, Luster MI. Immunotoxicity: bridging the gap between animal research and human health effects. Fundam Appl Toxicol 1995; 24:13-21.
26. Schlesinger RB, Fine JM, Chen LC. Interspecies differences in the phagocytic activity of pulmonary macrophages subjected to acidic challenge. Fundam Appl Toxicol 1992; 19:584-589.
27. Becker S, Soukup JM, Gilmour MI, Devlin RB. Stimulation of human and rat alveolar macrophages by urban air particulates: effects on oxidant radical generation and cytokine production. Toxicol Appl Pharmacol 1996; 141:637-648.
28. Dixon RE. Economic costs of respiratory tract infections in the United States. Am J Med 1985; 78(6B):45-51.
29. Chretien J, Holland W, Macklem P, Woolcock A. Acute respiratory infections in children: a global public health problem. N Engl J Med 1984; 310:982-984.
30. Berman S. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis 1991; 13:454-462.
31. Marcy TW, Merril WW. Cigarette smoking and respiratory tract infection. Clin Chest Med 1987; 8:381-391.
32. Department of Health and Human Services. The health consequences of smoking; chronic obstructive lung disease. A report of the Surgeon General. Rockville, MD: DHHS 1984.
33. Honicky RE, Osborne JS, Apcom CA. Symptoms of respiratory illness in young children and the use of wood burning stoves for indoor heating. Pediatrics 1985; 75:587-593.
34. Calder MA, Lutz W, Schonell ME. A 5 year study of bacteriology and prophylactic chemotherapy in patients with chronic bronchitis. Br J Dis Chest 1968; 62:93-108.
35. Paul R. Silicosis in northern Rhodesia copper mines. Arch Environ Health 1961; 2: 96-102.
36. Durck H. Studien uber Aetiologie und Histologie der Pneumonie im Kindesalter und der Pneumonie im Allgemeinen. Dtch Arch Klin Med 1896; 58:368-444.
37. Cesa Bianchi D. Staubinhalation und Lungentuberkulose. Z Hyg Infektionskrankh 1913; 73:166-181.
38. Kettle EH. The relation of dust to infection. Proc R Soc Med 1930; 24:79-94.
39. Coffin DL, Blommer EJ. Acute toxicity of irradiated auto exhaust. Arch Environ Health 1967; 15:36-38.
40. Hatch GE, Boykin E, Graham JA, Lewtas J, Pott F, Loud K, Mumford JL. Inhalable particles and pulmonary host defense: in vivo and in vitro effects of ambient air and combustion particles. Environ Res 1985; 36:67-80.
41. Pritchard RJ, Ghio AJ, Lehmann, JR, et al. Oxidant generation amd lung injury after particulate air pollutant exposure increases with the concentration of associated metals. Inhal Toxicol 1996; 8:457-478.
42. Green GM, Kass EH. The role of the alveolar macrophage in the clearance of bacteria from the lung. J Exp Med 1964; 119:167-176.
43. Jakab GJ. Relationship between carbon black particulate-bound formaldehyde, pulmonary antibacterial defenses, and alveolar macrophage phagocytosis. Inhal Toxicol 1992; 4:325-342.
44. Jakab GJ. The toxicologic interactions resulting from inhalation of carbon black and acrolein on pulmonary antibacterial and antiviral defenses. Toxicol Appl Pharmacol 1993; 121:165-175.
45. Rylander R. Pulmonary defense mechanisms to airborne bacteria. Acta Physiol Scand 1968; 306(supp):8-89.
46. Gilmour MI, Baskerville A, Taylor FGR, Wathes CM. The effect of titanium dioxide inhalation on the pulmonary clearance of Pasteurella haemolytica in the mouse. Environ Res 1989; 50:157-172.
47. Menzel DB. Ozone: an overview of its toxicity in man and animals. J Toxicol Environ Health 1984; 13:183-204.
48. Morrow PE. Dust overloading of the lungs: update and appraisal. Toxicol Appl Pharmacol 1992; 113:1-12.
49. Canning BJ, Hmieleski RR, Spannhake EW, Jakab GJ. Ozone reduces murine alveolar and peritoneal macrophage phagocytosis: the role of prostaglandins. Am J Physiol 1991; 261:L277-L282.
50. Hoidal JR, Niewoehner DE. Lung phagocytic recruitment and metabolic alterations induced by cigarette smoke in humans and in hamsters. Am Rev Respir Dis 1982; 126:548-552.
51. King TE, Savici D, Campbell PA. Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers. J Infect Dis 1988; 158: 1309-1316.
52. Ortega E, Barriga C, Rodriguez AB. Decline in the phagocytic function of alveolar macrophages from mice exposed to cigarette smoke. Comp Immunol Microbiol Infect Dis 1994; 17:77-84.
53. Rom WN, Bitterman PB, Rennard SI, Cantin A, Crystal RG. Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of organic dusts. Am Rev Respir Dis 1987; 136:1429-1434.
54. U.S. Environmental Protection Agency. An acid aerosols issue paper: health effects and aerometrics: Research Triangle Park, NC: Office of Health and Environmental Assessment, EPA report no. EPA-600/8-88-005F. Available from NTIS, Springfield, VA; PB91-125864, 1989.
55. Chen LC, Fine JM, Qu QS, Amdur MO, Gordon T. Effects of fine and ultrafine sulfuric acid aerosols in guinea pigs: alterations in alveolar macrophage function and intracellular pH. Toxicol Appl Pharmacol 1992; 113:109-117.
56. Jakab GJ, Hemenway DR. Inhalation co-exposure to carbon black and acrolein suppresses alveolar macrophage phagocytosis and TNF-a release and modulates peritoneal macrophage phagocytosis. Inhal Toxicol 1993; 5:275-289.
57. Moores HK, Janigan DT, Hajela RP. Lung injury after experimental smoke inhalation: particle associate changes in alveolar macrophages. Toxicol Pathol 1993; 21: 521-527.
58. Zelikoff JT, Parsons E, Schlesinger RB. Inhalation of particulate lead disrupts pulmonary macrophage-mediated functions important for host defense and tumor surveillance in the lung. Environ Res 1993; 62:207-222.
59. Zeigler B, Bhalla DK, Rasmussen RE, Kleinman MT, Menzel DB. Inhalation of resuspended road dust, but not ammonium nitrate decreases the expression of the pulmonary macrophage Fc receptor. Toxicol Lett 1994; 71:197-208.
60. Jakab GJ, Risby TH, Sehnert SS, Hmieleski RB, Gilmour MI. Suppression of alveolar macrophage membrane receptor-mediated phagocytosis by model particle adsorbate complexes: physico-chemical moderators of uptake. Environ Health Perspect 1991; 89:169-174.
61. Hadnagy W, Seemayer NH. Inhibition of phagocytosis of human macrophages induced by airborne particulates. Toxicol Lett 1994; 72:23-31.
62. Zelikoff JT, Schlesinger RB.Modulation of pulmonary immune defense mechanisms by sulfuric acid: effects on macrophage-derived tumor necrosis factor and superoxide. Toxicology 1992; 76:271-281.
63. Dong W, Lewtas J, Luster MI. Role of endotoxin in tumor necrosis factor alpha expression from alveolar macrophages treated with urban air particles. Exp Lung Res 1996; 22:577-592.
64. Zarkower A, Morges W. Alteration in antibody response induced by carbon inhalation: a model system. 1972; Infect Immun 5:915-920.
65. Miller SD, Zarkower A. Effects of carbon dust inhalation on the cell mediated immune response in mice. Infect Immun 1974; 9:534-539.
66. Miller SD, Zarkower A. Silica-induced alterations of murine lymphocyte immunocompetence and suppression of B lymphocyte immunocompetence. A possible mechanism. J Reticuloendothel Soc 1976; 19:46-61.
67. Eskew ML, Zarkower A, Scheuchenzuber WJ, Graham JA. Effects of fly ash inhalation on murine immune function: effect on systemic responses. Environ Res 1982; 28:375-385.
68. Gilmour MI, Wathes CM, Taylor FGR. Pulmonary clearance of Pasteurella haemolytica and immune responses in mice following exposure to titanium dioxide. Environ Res 1989; 50:184-194.
69. Bice DDE, Hahn FF, Benson J, Carpenter RL, Hobbs CH. Comparitive lung immunotoxicity of inhaled quartz and coal combustion fly ash. Environ Res 1987; 43: 374-389.
70. Johnson JD, Houchens DP, Kluwe WM, Craig DK, Fisher GL. Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol 1990; 20:369-395.
71. U.S. Environmental Protection Agency. Air quality criteria for lead. Research Triangle Park, NC: Office of Health and Environmental Assessment, EPA report no. EPA-600/8-83-028aF-dF.4v. Available from NTIS, Springfield, VA; PB87-142378, 1986.
72. Newcombe DS, Esa AH. Immunotoxicity of organophosphorus compounds. In: Newcombe DS, Rose NR, Bloom JC, eds. Clinical Immunotoxicology. New York: Raven Press, 1992:349-363.
73. Kowoleko M, McCabe MJ, Lawrence DA. Metal induced alterations of immunity. In: Newcombe DS, Rose NR, Bloom JC, eds. Clinical Immunotoxicology. New York: Raven Press, 1992:401-419.
74. Saboori AM, Newcombe DS. Environmental chemicals with immunotoxic properties. In: Newcombe DS, Rose NR, Bloom JC, eds. Clinical Immunotoxicology. New York: Raven Press, 1992:365-400.
75. Holt PG, Schon-Hegrad MA, Oliver J, Holt BJ, McMenamin PG. A contiguous network of dendritic antigen presenting cells within the respiratory epithelium. Int Arch Allergy Appl Immunol 1990; 91:155-159.
76. U.S. Department of Health and Human Services. Guidelines for the diagnosis and management of asthma. Publication 91-3042. Bethesda, MD: National Institutes of Health, 1991.
77. Bates DV, Sizto R. Hospital admissions and air pollutants in Southern Ontario: the acid summer haze effect. Environ Res 1987; 43:317-331.
78. Pierson WE, Koenig JQ. Respiratory effects of air pollution on allergic disease. J Allergy Clin Immunol 1992; 90:557-565.
79. Cody RP, Weisel CP, Birnbaum G, Lioy PJ. The effect of ozone associated with summertime photochemical smog and the frequency of asthma visits to hospital emergency departments. Environ Res 1992; 58:184-194.
80. Roemer W, Hoek G, Brunekreef B. Effect of ambient winter air pollution on respiratory health of children with chronic respiratory symptoms. Am Rev Respir Dis 1993; 147:118-124.
81. Pope CA. Respiratory disease associated with community air pollution and a steel mill, Utah Valley. Am J Public Health 1989; 79:623-628.
82. Pope CA. Respiratory hospital admissions associated with PM-10 pollution in Utah, Salt Lake, and Cache Valleys. Arch Environ Health 1991; 46:90-97.
83. Ishizaki T, Koizumi K, Ikemori R, et al. Studies of prevalence of Japanese cedar pollinosis among the residents in a densely cultivated area. Ann Allergy 1987; 58: 265-270.
84. Mosmann TR, Coffman RL. Two types of mouse T helper clone: implication for immune regulation. Immunol Today 1987; 8:233-236.
85. Robinson DS, Hamid Q, Ying S, et al. Predominant Th2-like bronchoalveolar T lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
86. Diaz-Sanchez D, Dotson AR, Takeaka H, Saxon A. Diesel exhaust particles induce local IgE production in vivo and alter the pattern of messenger RNA isoforms. J Clin Invest 1994; 94:1417-1425.
87. Takenaka H, Zhang K, Diaz-Sanchez D, Tsien A, Saxon A. Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B cell IgE production. J Allergy Clin Immunol 1995; 95:103-115.
88. Muranaka M, Suzuki S, et al. Adjuvant activity of diesel exhaust particulates for the production of IgE antibody in mice. J Allergy Clin Immunol 1986; 77:616-623.
89. Takafuji S, Suzuki S, Koizumi K, et al. Diesel exhaust particulates inoculated by the intranasal route have an adjuvant activity for IgE production in mice. J Allergy Clin Immunol 1987; 79:639-645.
90. Fujimaki H, Nohara O, Ichinose T, Watanabe N, Saito S. IL4 production in mediastinal lymph node cells in mice intratracheally instilled with diesel exhaust particles and antigen. Toxicology 1994; 92:261-268.
91. Luster MI, Portier C, Pait DG, et al. Risk assessment in immunotoxicology II. Relationships between immune and host resistance tests. Fundam Appl Toxicol 1993; 21:71-82.
92. Selgrade MJ, Lawrence DA, Ullrich SE, Gilmour MI, Schuyler MR, Kimber I. Modulation of T-helper populations; potential mechanisms of respiratory hypersensitivity and immune suppression. Toxicol Appl Pharmacol 1997; 145:219-229.
93. Ulrich SE. Mechanism involved in the systemic suppression of antigen presenting cell function by UV irradiation. J Immunol 1994; 152:3410-3416.